Considering that BGN overexpression increases lipid retention and atherosclerosis development [18–21], the finding that BGN transcription is upregulated in the dMCA cell population suggests that BGN may play an important role in the development of ICAD and potentially serve as a novel drug target for the disease. This evidence concerns the gene BGN and atherosclerosis.